Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Amrut Ambardekar to Amyloidosis

This is a "connection" page, showing publications Amrut Ambardekar has written about Amyloidosis.

 
Connection Strength
 
 
 
1.867
 
  1. Ambardekar AV, Fontana M, Maurer MS, Trachtenberg B, Kittleson M. How to Identify Cardiac Amyloidosis Patients Who Might Benefit From Cardiac Transplantation. JACC Heart Fail. 2023 01; 11(1):115-120.
    View in: PubMed
    Score: 0.826
  2. Ambardekar AV. When You Hear Hoof Beats, Think?of?the?Treatable Zebras. JACC Heart Fail. 2019 11; 7(11):967-969.
    View in: PubMed
    Score: 0.661
  3. Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, Dember LM, Frantz JG, Hershberger RE, Maurer MS, Nativi-Nicolau J, Sanchorawala V, Sheikh FH. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient?With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 03 21; 81(11):1076-1126.
    View in: PubMed
    Score: 0.207
  4. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J, Ruberg FL. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020 07 07; 142(1):e7-e22.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)